COVID-19 Antibodies Among Healthcare Workers

Hospital Universitario Dr. Jose E. Gonzalez156 enrolled

Overview

Observational, point of prevalence study determining the presence of anti-SARS-CoV-2 antibody

All Healthcare workers (HCW) who had entered contaminated areas at least once and that 14 days or more had passed from their first entrance to contaminated areas were included. They were classified as asymptomatic and pauci-symptomatic. A COVID-19 IgG/IgM rapid test was used for antibody detection, and selected participants were subject to real time polymerase chain reaction (qPCR) for SARS-CoV-2.

Study Type

OBSERVATIONAL

Enrollment

156

Conditions

COVID-19 SARS-CoV 2

Interventions

COVID-19 IgG/IgM Rapid Test Cassette test (Healgen Scientific, Houston, Texas, USA)DIAGNOSTIC_TEST

a blood sample is drained for detection of IgG and IgM antibody

Eligibility

Sex: ALLMin age: 18 YearsMax age: 99 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * All healthcare workers who had entered contaminated areas at least once and that 14 days or more had passed from their first entrance were included Exclusion Criteria: * Healthcare workers who did not have exposure for more or equal 14 days * Healthcare workers who did not wish to participate

Locations (1)

Hospital Universitario José E. Gonzalez

Monterrey, Nuevo León, Mexico

Outcomes

Primary Outcomes

Presence of antibody

presence of IgG and/or IgM against SARS-CoV-2

Time frame: through study completion, an average of 8 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.